{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:50:22Z","timestamp":1790952622731,"version":"4.1.0"},"reference-count":28,"publisher":"Society of Nuclear Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2025,2,3]]},"published-print":{"date-parts":[[2025,4]]},"DOI":"10.2967\/jnumed.124.268508","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T12:07:42Z","timestamp":1741349262000},"page":"599-604","source":"Crossref","is-referenced-by-count":10,"title":["Preclinical Evaluation of<sup>177<\/sup>Lu-rhPSMA-10.1, a Radiopharmaceutical for Prostate Cancer: Biodistribution and Therapeutic Efficacy"],"prefix":"10.2967","volume":"66","author":[{"given":"Caroline","family":"Foxton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Waldron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikke","family":"Veggerby Gr\u00f8nlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime (Jim)","family":"Sim\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Cornelissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"O\u2019Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2025,3,6]]},"reference":[{"key":"2025040211001540000_66.4.599.1","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.eururo.2018.11.016","article-title":"Treatment outcome, toxicity, and predictive factors for radioligand therapy with 177Lu-PSMA-I&T in metastatic castration-resistant prostate cancer","volume":"75","author":"Heck","year":"2019","journal-title":"Eur Urol."},{"key":"2025040211001540000_66.4.599.2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262671"},{"key":"2025040211001540000_66.4.599.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107322"},{"key":"2025040211001540000_66.4.599.4","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30198-0"},{"key":"2025040211001540000_66.4.599.5","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1097\/JU.0000000000003226.07","article-title":"Radioligand therapy with 177Lu-PSMA-I&T in patients with metastatic castration-resistant prostate cancer: oncological outcomes and toxicity profile","volume":"209","author":"Demirkol","year":"2023","journal-title":"J Urol."},{"key":"2025040211001540000_66.4.599.6","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s12149-021-01649-w","article-title":"177Lu-PSMA-RLT of metastatic castration-resistant prostate cancer: limitations and improvements","volume":"35","author":"Cao","year":"2021","journal-title":"Ann Nucl Med."},{"key":"2025040211001540000_66.4.599.7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.eururo.2022.05.025","article-title":"Extensive 177Lu-PSMA radioligand therapy can lead to radiation nephropathy with a renal thrombotic microangiopathy-like picture","volume":"83","author":"Schafer","year":"2023","journal-title":"Eur Urol."},{"key":"2025040211001540000_66.4.599.8","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.219352"},{"key":"2025040211001540000_66.4.599.9","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.1200\/JCO.2022.40.16_suppl.5002","article-title":"[68Ga]Ga-PSMA-11 PET baseline imaging as a prognostic tool for clinical outcomes to [177Lu]Lu-PSMA-617 in patients with mCRPC: a VISION substudy","volume":"40","author":"Kuo","year":"2022","journal-title":"J Clin Oncol."},{"key":"2025040211001540000_66.4.599.10","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.178483"},{"key":"2025040211001540000_66.4.599.11","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.234922"},{"key":"2025040211001540000_66.4.599.12","unstructured":"POSLUMA (flotufolastat F 18) injection, for intravenous use. FDA website. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/216023s000lbl.pdf. Published May 2023. Accessed February 13, 2025."},{"key":"2025040211001540000_66.4.599.13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/JU.0000000000003493","article-title":"Diagnostic performance and safety of 18F-rhPSMA-7.3 PET in men with suspected prostate cancer recurrence: results from a phase 3, prospective, multicenter study (SPOTLIGHT)","volume":"210","author":"Jani","year":"2023","journal-title":"J Urol."},{"key":"2025040211001540000_66.4.599.14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.eururo.2023.06.018","article-title":"Diagnostic performance and safety of positron emission tomography with 18F-rhPSMA-7.3 in patients with newly diagnosed unfavourable intermediate to very high-risk prostate cancer: results from a phase 3, prospective, multicentre study (LIGHTHOUSE)","volume":"84","author":"Surasi","year":"2023","journal-title":"Eur Urol."},{"key":"2025040211001540000_66.4.599.15","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.263371"},{"key":"2025040211001540000_66.4.599.16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s41181-024-00246-2","article-title":"Preclinical comparison of [177Lu]Lu-rhPSMA-10.1 and [177Lu]Lu-rhPSMA-10.2 for endoradiotherapy of prostate cancer: biodistribution and dosimetry studies","volume":"9","author":"Wurzer","year":"2024","journal-title":"EJNMMI Radiopharm Chem."},{"key":"2025040211001540000_66.4.599.17","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-11-0191"},{"key":"2025040211001540000_66.4.599.18","first-page":"115","article-title":"Hematological and plasma biochemical values in four specific pathogen-free mice strains produced in the animal facility at Cantacuzino Institute","volume":"64","author":"Coman","year":"2018","journal-title":"Scientific Works Series C Vet Med."},{"key":"2025040211001540000_66.4.599.19","unstructured":"Brayton C . Phenotyping core. Johns Hopkins website. https:\/\/mcp.bs.jhmi.edu\/phenotyping-core\/. Accessed February 13, 2025."},{"key":"2025040211001540000_66.4.599.20","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.147413"},{"key":"2025040211001540000_66.4.599.21","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.254516"},{"key":"2025040211001540000_66.4.599.22","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.158550"},{"key":"2025040211001540000_66.4.599.23","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.212720"},{"key":"2025040211001540000_66.4.599.24","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.265448"},{"key":"2025040211001540000_66.4.599.25","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.266741"},{"key":"2025040211001540000_66.4.599.26","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.265970"},{"key":"2025040211001540000_66.4.599.27","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/MNM.0000000000001658","article-title":"Kidney absorbed radiation doses for [177Lu]Lu-PSMA-617 and [177Lu]Lu-PSMA-I&T determined by 3D clinical dosimetry","volume":"44","author":"Uijen","year":"2023","journal-title":"Nucl Med Commun."},{"key":"2025040211001540000_66.4.599.28","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262713"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.124.268508","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T18:07:02Z","timestamp":1743617222000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.124.268508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,6]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4,1]]},"published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.2967\/jnumed.124.268508"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.124.268508","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,6]]}}}